Table 1

Clinicopathological profiles and detection of URP II mRNA-positive cells in peripheral blood of patients with clinically localized urothelial cancers

Patient No.Age/SexPrimary siteGroupTumorUP II-positive cells
GradeStageSize (cm)No.
380 /FBa/US3a1–32–4
1549 /MBS31a1–32–4
1676 /MUS1a1–31
1966 /MBS2a1–3≥5
2072 /FBS2a<12–4
2135/ MBS2a1–3≥5
2264 /MBS3x3–51
2370 /MBS21b1–32–4
2474 /MBS2a<12–4
2576 /MBS1a<1≥5+
2884 /MBS1a<11
2972 /MBS1a1–32–4
3162 /MBS3a<11
3269 /MBS2a1–31
3469 /MBS1a<12–4
3575 /FBS1a1–31
3680 /MBS2a1–32–4
3758 /MBS2a1–3≧5+
4073 /MBS1a<12–4
4174 /FBS1a<11
4275 /MBS1a3–5≧5+
4379 /FBS1a3–51
4468 /FBS1a<1≧5
4565 /FBS1a<1≧5
4772 /MBS2a1–3≧5
4875 /MBS2a<11
4971 /MBS1a<11
5468 /FPS2a>51
6087 /MBS31b1–3≧5
182 /MUI34>51+
1476 /MBI33b1–31
1865 /MUI3212–4
2687 /FBI22>51
2766 /MBI321–31
3064 /MBI34<12–4+
3983 /FBI23b3–51
4654 /MPI33>51
5073 /MBI23b>11
5154 /MBI??>51
5273 /FPI33>51
5580 /MUI33>11+
5655 /FBI32<12–4+
5781 /FBI341–31
  • a B, bladder; U, ureter; P, renal pelvis; S, superficial, I, invasive.